A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

Clinical trial NCT04630353 · TERMINATED

Trial details

NCT number: NCT04630353
Sponsor: Hookipa Biotech GmbH
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer

Start date: 2021-07-28
Primary completion: 2023-11-28
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.